Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|May 4, 2010
Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitisBruce M Prenner, Bobby Q Lanier, David I Bernstein, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 4, 2022
Efficacy and safety of GSP301 nasal spray in children aged 6 to 11 years with seasonal allergic rhinitisBruce M Prenner, Niran J Amar, Frank C Hampel, et al.Allergy and Asthma Proceedings|August 13, 2008
Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patientsStephen P Peters, Bruce M Prenner, William S Mezzanotte, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 27, 2007
Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitisPaul Chervinsky, Sudeesha Kunjibettu, David L Miller, et al.American Journal of Rhinology & Allergy|April 9, 2013
Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitisEli O Meltzer, David I Bernstein, Bruce M Prenner, et al.Current Medical Research and Opinion|July 3, 2013
Efficacy, safety, and optimal dose selection of beclomethasone dipropionate nasal aerosol for seasonal allergic rhinitis in adolescents and adultsGordon D Raphael, William E Berger, Bruce M Prenner, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 11, 2015
Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mitesJennifer Maloney, Bruce M Prenner, David I Bernstein, et al.Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroidsWilliam E Berger, Edward Kerwin, David I Bernstein, et al.Current Medical Research and Opinion|June 15, 2007
Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challengeFrancis S Mah, Lanny J Rosenwasser, William D Townsend, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 6, 2008
Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhalerPaul Chervinsky, James Baker, George Bensch, et al.Pageof 3